India city Ahmedabad covid-19 vaccine India city Ahmedabad

Zydus Cadila submits additional data on its Covid vaccine to DCGI: Report

Reading now: 836
www.livemint.com

Zydus Cadila is learnt to have submitted additional data related to immunogenicity and safety to India's drug regulator, reported news agency ANI quoting sources.

The Drug Controller General of India (DCGI) had earlier asked the Ahmedabad-based firm to return with more data on its Zycov-D.

The regulator's Subject Expert Committee (SEC) will examine the additional data and decide on granting the emergency use authorisation (EUA) based on it.

Previously, the ANI had reported that a continuous and rolling review of data was being undertaken and final approval would take a few more days. Approval for Zydus Cadila The Ahmedabad-based pharmaceutical firm had on 1 July applied for emergency use authorization of its ZyCoV-D three-dose

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA